Literature DB >> 16125865

Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats.

J M Shoemaker1, R L Saint Marie, M J Bongiovanni, A C Neary, L S Tochen, N R Swerdlow.   

Abstract

BACKGROUND: Sensorimotor gating, as measured by prepulse inhibition of the startle reflex, is deficient in schizophrenia patients, and in rats after specific manipulations of limbic cortico-striato-pallido-thalamic circuitry. For example, prepulse inhibition in rats is disrupted after D1 blockade in the medial prefrontal cortex, and after N-methyl-D-aspartate infusion into the ventral hippocampus. In the present study, we examined whether these two substrates form part of an integrated circuit regulating sensorimotor gating, which might contribute to the loss of prepulse inhibition in patient populations.
METHODS: Prepulse inhibition was assessed in male Sprague-Dawley rats after systemic or intra-medial prefrontal cortex administration of the D1 antagonist, SCH 23390. Separate rats received intra-medial prefrontal cortex infusion of the retrograde transported label Fluoro-Gold. In rats with sham or electrolytic lesions of the medial prefrontal cortex, prepulse inhibition was tested after infusion of N-methyl-D-aspartate or vehicle into ventral hippocampus regions that were determined to send projections to the medial prefrontal cortex.
RESULTS: Prepulse inhibition was disrupted after systemic SCH 23390 treatment and after infusion of SCH 23390 into medial prefrontal cortex sites within the prelimbic and cingulate cortices. Fluoro-Gold infusion into these medial prefrontal cortex sites labeled cells in the ventral hippocampus complex, including regions CA1 and entorhinal cortex. N-methyl-D-aspartate infusions into these ventral hippocampus regions disrupted prepulse inhibition in rats after sham but not electrolytic lesions of the medial prefrontal cortex.
CONCLUSIONS: Prepulse inhibition appears to be regulated by interacting substrates within the ventral hippocampus and MPFC. Specifically, NMDA activation of the ventral hippocampus appears to disrupt prepulse inhibition in a manner that is dependent on the integrity of infralimbic or cingulate cortical regions that also support a D1-mediated regulation of prepulse inhibition. Conceivably, dysfunction within these hippocampal-frontal circuits may contribute to sensorimotor gating deficits in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125865      PMCID: PMC1364454          DOI: 10.1016/j.neuroscience.2005.06.054

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  61 in total

1.  Regulation of prepulse inhibition by ventral pallidal projections.

Authors:  M H Kodsi; N R Swerdlow
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

2.  Excitatory Amino Acid Pathway from the Hippocampus to the Prefrontal Cortex. Contribution of AMPA Receptors in Hippocampo-prefrontal Cortex Transmission.

Authors:  Thérèse M. Jay; Anne-Marie Thierry; Leif Wiklund; Jacques Glowinski
Journal:  Eur J Neurosci       Date:  1992       Impact factor: 3.386

3.  Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis.

Authors:  L J Seidman; S V Faraone; J M Goldstein; J M Goodman; W S Kremen; R Toomey; J Tourville; D Kennedy; N Makris; V S Caviness; M T Tsuang
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

4.  Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents.

Authors:  F Condé; E Maire-Lepoivre; E Audinat; F Crépel
Journal:  J Comp Neurol       Date:  1995-02-20       Impact factor: 3.215

5.  Projections of the entorhinal area to the striatum, nucleus accumbens, and cerebral cortex in the guinea pig.

Authors:  K E Sørensen
Journal:  J Comp Neurol       Date:  1985-08-15       Impact factor: 3.215

Review 6.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

7.  The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity.

Authors:  F J Wan; S B Caine; N R Swerdlow
Journal:  Eur J Pharmacol       Date:  1996-10-24       Impact factor: 4.432

8.  Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions.

Authors:  F J Wan; N R Swerdlow
Journal:  Brain Res       Date:  1996-05-25       Impact factor: 3.252

9.  Topographically specific hippocampal projections target functionally distinct prefrontal areas in the rhesus monkey.

Authors:  H Barbas; G J Blatt
Journal:  Hippocampus       Date:  1995       Impact factor: 3.899

10.  Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat.

Authors:  S Schmadel; K Schwabe; M Koch
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  20 in total

1.  Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats.

Authors:  R L Saint Marie; E J Miller; M R Breier; M Weber; N R Swerdlow
Journal:  Neuroscience       Date:  2010-03-23       Impact factor: 3.590

Review 2.  Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms.

Authors:  Fabio Fumagalli; Angelisa Frasca; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.

Authors:  Tariq W Chohan; Aurelie A Boucher; Jarrah R Spencer; Mustafa S Kassem; Areeg A Hamdi; Tim Karl; Sandra Y Fok; Maxwell R Bennett; Jonathon C Arnold
Journal:  Schizophr Bull       Date:  2014-01-17       Impact factor: 9.306

4.  Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

Authors:  Karen M Alsene; Katie Fallace; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

5.  Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.

Authors:  Laura J Mosher; Roberto Frau; Alessandra Pardu; Romina Pes; Paola Devoto; Marco Bortolato
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

6.  Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

8.  Schizophrenia diagnosis and anterior hippocampal volume make separate contributions to sensory gating.

Authors:  Robert J Thoma; Faith M Hanlon; Helen Petropoulos; Gregory A Miller; Sandra N Moses; Ashley Smith; Lauren Parks; S Laura Lundy; Natalie M Sanchez; Aaron Jones; Mingxiong Huang; Michael P Weisend; Jose M Cañive
Journal:  Psychophysiology       Date:  2008-09-24       Impact factor: 4.016

Review 9.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

10.  Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons.

Authors:  Hiroyuki Mizoguchi; Sawako Arai; Hiroyuki Koike; Daisuke Ibi; Hiroyuki Kamei; Toshitaka Nabeshima; Hyoung-Chun Kim; Kazuhiro Takuma; Kiyofumi Yamada
Journal:  Psychopharmacology (Berl)       Date:  2009-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.